Oral Ketorolac for IUD Pain Reduction

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 23, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
IUD Insertion Pain
Interventions
DRUG

Ketorolac

The experimental condition to be examined by this study is the timing of administration of ketorolac prior to IUD insertion. Ketorolac 20mg PO has proven beneficial at certain timepoints during IUD insertion in prior studies, but pharmacokinetics indicate that it could require more time until peak analgesia.

DRUG

Placebo

Placebo will be used to control the timing of administration and be used to compare ketorolac to baseline standard pain control regimens

Trial Locations (1)

27278

University of North Carolina - Hillsborough Campus, Hillsborough

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER